https://www.selleckchem.com/
0195], whereas among individuals with or without schizoaffective disorder, the risk of developing T1DM did not differ [adjusted HR (95% CI) 1.23 (0.17-8.74), p=0.8377]. The risk of developing T2DM was significantly higher both among individuals with schizophrenia and schizoaffective disorder, than among those without such diagnoses [adjusted HR (95% CI) 13.98 (8.70-22.46), p0.0001 and 14.27 (7.36-27.7, p0.0001, respectively]. This study shows that schizophrenia is associated with increased risk for subsequent T1DM. It also shows that both schizoph